Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Baron

Showing results (941-950 of 1,006) with videos related to

Pageof 101
Sort By:
Human Mutation|December 21, 2012
Cancer risks for MLH1 and MSH2 mutation carriersJames G Dowty, Aung K Win, Daniel D Buchanan, et al.
Gastroenterology|July 17, 2007
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based studyMark A Jenkins, Shinichi Hayashi, Anne-Marie O'Shea, et al.
JAMA|June 7, 2007
Folic acid for the prevention of colorectal adenomas: a randomized clinical trialBernard F Cole, John A Baron, Robert S Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registryMichael D Walsh, Daniel D Buchanan, Margaret C Cummings, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2015
Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotypePeter T Campbell, Christina C Newton, Polly A Newcomb, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Plos One|July 28, 2010
Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinicsDaniel D Buchanan, Kevin Sweet, Musa Drini, et al.
Blood Advances|April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter StudyNikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Journal of the National Cancer Institute|December 24, 2009
Risks of Lynch syndrome cancers for MSH6 mutation carriersLaura Baglietto, Noralane M Lindor, James G Dowty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2015
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer RiskAaron P Thrift, Jian Gong, Ulrike Peters, et al.
Pageof 101

Showing results (941-950 of 1,006) with videos related to

Sort By:
Pageof 101
Human Mutation|December 21, 2012
Cancer risks for MLH1 and MSH2 mutation carriersJames G Dowty, Aung K Win, Daniel D Buchanan, et al.
Gastroenterology|July 17, 2007
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based studyMark A Jenkins, Shinichi Hayashi, Anne-Marie O'Shea, et al.
JAMA|June 7, 2007
Folic acid for the prevention of colorectal adenomas: a randomized clinical trialBernard F Cole, John A Baron, Robert S Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registryMichael D Walsh, Daniel D Buchanan, Margaret C Cummings, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2015
Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotypePeter T Campbell, Christina C Newton, Polly A Newcomb, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Plos One|July 28, 2010
Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinicsDaniel D Buchanan, Kevin Sweet, Musa Drini, et al.
Blood Advances|April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter StudyNikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Journal of the National Cancer Institute|December 24, 2009
Risks of Lynch syndrome cancers for MSH6 mutation carriersLaura Baglietto, Noralane M Lindor, James G Dowty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2015
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer RiskAaron P Thrift, Jian Gong, Ulrike Peters, et al.
Pageof 101